News

Filter

Current filters:

AmgenEli Lilly

Systemic psoriasis market forecast to reach $10.4 billion by 2020

05-02-2014

The systemic psoriasis treatment market value in the eight major countries (8MM) - the USA, Canada, France,…

AmgenapremilastBiotechnologybrodalumabCelgeneDermatologicalsEli LillyMarkets & MarketingNovartisPfizersecukinumabXeljanz

ASBMR 2012: Anabolics and post-marketing studies

25-10-2012

This year's American Society for Bone and Mineral Research (ASBMR) conference, held in Minneapolis, Minnesota,…

AmgenAnti-Arthritics/RheumaticsBiotechnologyEli LillyMerck & CoodanacatibPharmaceuticalProliaResearchteriparatideUnigene Labs

Intercell’s Travelers’ diarrhea vaccine and Lilly’s tasisulam flop; Amgen’s Xgeva looks good

14-12-2010

Austria-headquartered Intercell AG (VSE: ICLL) saw its shares plunge 41% to 10 euros by close of trading…

AmgenEli LillyGastro-intestinalsIntercellOncologyPharmaceuticalResearchtasisulamXgeva

COMPANY SPOTLIGHT

Menarini

Back to top